05 October 2021 | News
With a commitment of $50 million over five years
image credit- shutterstock
Japan-based Olympus Corporation is establishing Olympus Innovation Ventures, LLC as a corporate venture capital fund.
In recent years, the pace of innovation has been accelerating, and new trends such as digital, AI and robotics are shifting the medtech landscape. In order to take advantage of these opportunities and to create opportunities for us to grow, the company has decided to establish a corporate venture capital fund, that will allow to form relationships with early stage companies and help nurture partnerships with relevant and compelling entrepreneurial teams.
Olympus will initially commit a total of $50 million over five years for Olympus Ventures to search, identify, vet and invest in early stage companies with differentiated technologies.
Olympus Ventures is intended to deliver benefits such as: (1) Build a pipeline of future M&A targets (2) Spot critical trends in technology, medicine, and care delivery (3) Identify promising new markets for future growth (4) Generate financial return on invested capital (5) Raise Olympus’ profile in the Medtech innovation ecosystem.